3724 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

will be valid for two years unless 

rescinded earlier by FMCSA. The 

exemption will be rescinded if: (1) The 

person fails to comply with the terms 

and conditions of the exemption; (2) the 

exemption has resulted in a lower level 

of safety than was maintained before it 

was granted; or (3) continuation of the 

exemption would not be consistent with 

the goals and objectives of 49 U.S.C. 

31136(e) and 31315. 

III. Basis for Renewing Exemptions 

Under 49 U.S.C. 31315(b)(1), an 

exemption may be granted for no longer 

than two years from its approval date 

and may be renewed upon application 

for additional two year periods. In 

accordance with 49 U.S.C. 31136(e) and 

31315, each of the 27 applicants has 

satisfied the entry conditions for 

obtaining an exemption from the vision 

requirements (65 FR 45821; 65 FR 

77066; 67 FR 54525; 67 FR 68719; 68 FR 

1654; 68 FR 2629; 68 FR 8794; 69 FR 

64806; 69 FR 71098; 69 FR 71100; 70 FR 

2705; 70 FR 8659; 71 FR 63380; 72 FR 

1050; 72 FR 1054; 72 FR 1056; 72 FR 

5489; 73 FR 51689; 73 FR 63047; 73 FR 

75803; 73 FR 76439; 73 FR 78421; 74 FR 

981; 74 FR 6207; 74 FR 6209; 75 FR 

1835; 75 FR 34209; 75 FR 47883; 75 FR 

47886; 75 FR 63255; 75 FR 72863; 75 FR 

77942; 75 FR 79083; 75 FR 79084; 75 FR 

9482; 76 FR 2190; 76 FR 4413; 76 FR 

4414; 76 FR 5425; 76 FR 8809; 77 FR 

23799; 77 FR 33558; 77 FR 70534; 77 FR 

74731; 77 FR 75496; 78 FR 1919; 78 FR 

9772; 78 FR 12811; 78 FR 12813; 78 FR 

12817). Each of these 27 applicants has 

requested renewal of the exemption and 

has submitted evidence showing that 

the vision in the better eye continues to 

meet the requirement specified at 49 

CFR 391.41(b)(10) and that the vision 

impairment is stable. In addition, a 

review of each record of safety while 

driving with the respective vision 

deficiencies over the past two years 

indicates each applicant continues to 

meet the vision exemption 

requirements. 

These factors provide an adequate 

basis for predicting each driver’s ability 

to continue to drive safely in interstate 

commerce. Therefore, FMCSA 

concludes that extending the exemption 

for each renewal applicant for a period 

of two years is likely to achieve a level 

of safety equal to that existing without 

the exemption. 

IV. Public Participation and Request for 

Comments 

FMCSA encourages you to participate 

by submitting comments and related 

materials. 

Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (FMCSA–2000–7363; FMCSA– 

2002–12432; FMCSA–2002–12844; 

FMCSA–2002–19477; FMCSA–2006– 

26066; FMCSA–2008–0266; FMCSA– 

2008–0340; FMCSA–2009–0321; 

FMCSA–2010–0114; FMCSA–2010– 

0187; FMCSA–2010–0354; FMCSA– 

2010–0385; FMCSA–2012–0040; 

FMCSA–2012–0337; FMCSA–2012– 

0338; FMCSA–2012–0339), indicate the 

specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. You may submit your 

comments and material online or by fax, 

mail, or hand delivery, but please use 

only one of these means. FMCSA 

recommends that you include your 

name and a mailing address, an email 

address, or a phone number in the body 

of your document so the Agency can 

contact you if it has questions regarding 

your submission. 

To submit your comment online, got 

to http://www.regulations.gov and put 

the docket number, ‘‘FMCSA–2000– 

7363; FMCSA–2002–12432; FMCSA– 

2002–12844; FMCSA–2002–19477; 

FMCSA–2006–26066; FMCSA–2008– 

0266; FMCSA–2008–0340; FMCSA– 

2009–0321; FMCSA–2010–0114; 

FMCSA–2010–0187; FMCSA–2010– 

0354; FMCSA–2010–0385; FMCSA– 

2012–0040; FMCSA–2012–0337; 

FMCSA–2012–0338; FMCSA–2012– 

0339’’ in the ‘‘Keyword’’ box, and click 

‘‘Search.’’ When the new screen 

appears, click on ‘‘Comment Now!’’ 

button and type your comment into the 

text box in the following screen. Choose 

whether you are submitting your 

comment as an individual or on behalf 

of a third party and then submit. If you 

submit your comments by mail or hand 

delivery, submit them in an unbound 

format, no larger than 81⁄2 by 11 inches, 

suitable for copying and electronic 

filing. If you submit comments by mail 

and would like to know that they 

reached the facility, please enclose a 

stamped, self-addressed postcard or 

envelope. FMCSA will consider all 

comments and material received during 

the comment period and may change 

this notice based on your comments. 

Viewing Comments and Documents 

To view comments, as well as any 

documents mentioned in this preamble 

as being available in the docket, go to 

http://www.regulations.gov and in the 

search box insert the docket number, 

‘‘FMCSA–2000–7363; FMCSA–2002– 

12432; FMCSA–2002–12844; FMCSA– 

2002–19477; FMCSA–2006–26066; 

FMCSA–2008–0266; FMCSA–2008– 

0340; FMCSA–2009–0321; FMCSA– 

2010–0114; FMCSA–2010–0187; 

FMCSA–2010–0354; FMCSA–2010– 

0385; FMCSA–2012–0040; FMCSA– 

2012–0337; FMCSA–2012–0338; 

FMCSA–2012–0339’’ in the ‘‘Keyword’’ 

box and click ‘‘Search.’’ Next, click 

‘‘Open Docket Folder’’ button choose 

the document listed to review. If you do 

not have access to the Internet, you may 

view the docket online by visiting the 

Docket Management Facility in Room 

W12–140 on the ground floor of the 

DOT West Building, 1200 New Jersey 

Avenue SE., Washington, DC 20590, 

between 9 a.m. and 5 p.m., e.t., Monday 

through Friday, except Federal holidays. 

Issued on: January 12, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–01199 Filed 1–22–15; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2014–0312] 

Qualification of Drivers; Exemption 

Applications; Diabetes Mellitus 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), Department 

of Transportation. 

ACTION: Notice of applications for 

exemptions request for comments. 

SUMMARY: FMCSA announces receipt of 

applications from 69 individuals for 

exemption from the prohibition against 

persons with insulin-treated diabetes 

mellitus (ITDM) operating commercial 

motor vehicles (CMVs) in interstate 

commerce. If granted, the exemptions 

would enable these individuals with 

ITDM to operate CMVs in interstate 

commerce. 

DATES: Comments must be received on 

or before February 23, 2015. 

ADDRESSES: You may submit comments 

bearing the Federal Docket Management 

System (FDMS) Docket No. FMCSA– 

2014–0312 using any of the following 

methods: 

• Federal eRulemaking Portal: Go to 

http://www.regulations.gov. Follow the 

on-line instructions for submitting 

comments. 

• Mail: Docket Management Facility; 

U.S. Department of Transportation, 1200 

New Jersey Avenue SE., West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 3725 

New Jersey Avenue SE., Washington, 

DC, between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal 

Holidays. 

• Fax: 1–202–493–2251. 

Instructions: Each submission must 

include the Agency name and the 

docket numbers for this notice. Note 

that all comments received will be 

posted without change to http://

www.regulations.gov, including any 

personal information provided. Please 

see the Privacy Act heading below for 

further information. 

Docket: For access to the docket to 

read background documents or 

comments, go to http://

www.regulations.gov at any time or 

Room W12–140 on the ground level of 

the West Building, 1200 New Jersey 

Avenue SE., Washington, DC, between 9 

a.m. and 5 p.m., Monday through 

Friday, except Federal holidays. The 

Federal Docket Management System 

(FDMS) is available 24 hours each day, 

365 days each year. If you want 

acknowledgment that we received your 

comments, please include a selfaddressed, stamped envelope or 

postcard or print the acknowledgement 

page that appears after submitting 

comments on-line. 

Privacy Act: In accordance with 5 

U.S.C. 553(c), DOT solicits comments 

from the public to better inform its 

rulemaking process. DOT posts these 

comments, without edit, including any 

personal information the commenter 

provides, to www.regulations.gov, as 

described in the system of records 

notice (DOT/ALL–14 FDMS), which can 

be reviewed at www.dot.gov/privacy. 

FOR FURTHER INFORMATION CONTACT: 

Charles A. Horan, III, Director, Office of 

Carrier, Driver and Vehicle Safety, (202) 

366–4001, fmcsamedical@dot.gov, 

FMCSA, Department of Transportation, 

1200 New Jersey Avenue SE., Room 

W64–224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., Monday through Friday, except 

Federal holidays. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Under 49 U.S.C. 31136(e) and 31315, 

FMCSA may grant an exemption from 

the Federal Motor Carrier Safety 

Regulations for a 2-year period if it finds 

‘‘such exemption would likely achieve a 

level of safety that is equivalent to or 

greater than the level that would be 

achieved absent such exemption.’’ The 

statute also allows the Agency to renew 

exemptions at the end of the 2-year 

period. The 69 individuals listed in this 

notice have recently requested such an 

exemption from the diabetes prohibition 

in 49 CFR 391.41(b)(3), which applies to 

drivers of CMVs in interstate commerce. 

Accordingly, the Agency will evaluate 

the qualifications of each applicant to 

determine whether granting the 

exemption will achieve the required 

level of safety mandated by statute. 

II. Qualifications of Applicants 

Bryan L. Anderson 

Mr. Anderson, 30, has had ITDM 

since 2010. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Anderson understands diabetes 

management and monitoring, has stable 

control of his diabetes using insulin, 

and is able to drive a CMV safely. Mr. 

Anderson meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

His optometrist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from Washington. 

Travis K. Archer 

Mr. Archer, 30, has had ITDM since 

1996. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Archer understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Archer meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds an operator’s license from 

Maine. 

Michael R. Batham 

Mr. Batham, 31, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Batham understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Batham meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from California. 

Victor M. Beltran-Araujo 

Mr. Beltran Araujo, 43, has had ITDM 

since 2009. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Beltran Araujo understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Beltran Araujo meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds a Class A CDL from Idaho. 

Charles A. Best 

Mr. Best, 31, has had ITDM since 

2000. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Best understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Best meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from Ohio. 

Cassandra J. Braford 

Ms. Braford, 31, has had ITDM since 

2014. Her endocrinologist examined her 

in 2014 and certified that she has had 

no severe hypoglycemic reactions 

resulting in loss of consciousness, 

requiring the assistance of another 

person, or resulting in impaired 


tkelley on DSK3SPTVN1PROD with NOTICES
3726 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

cognitive function that occurred without 

warning in the past 12 months and no 

recurrent (2 or more) severe 

hypoglycemic episodes in the last 5 

years. Her endocrinologist certifies that 

Ms. Braford understands diabetes 

management and monitoring has stable 

control of her diabetes using insulin, 

and is able to drive a CMV safely. Ms. 

Braford meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

Her optometrist examined her in 2014 

and certified that she does not have 

diabetic retinopathy. She holds an 

operator’s license from Minnesota. 

Mark E. Buchholz 

Mr. Buchholz, 50, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Buchholz understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Buchholz meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds an operator’s license from 

South Dakota. 

Richard E. Buthy 

Mr. Buthy, 66, has had ITDM since 

2006. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Buthy understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Buthy meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds an 

operator’s license from New Jersey. 

George E. Carle 

Mr. Carle, 61, has had ITDM since 

2004. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Carle understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Carle meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Colorado. 

Jamey S. Carney 

Mr. Carney, 45, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Carney understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Carney meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Iowa. 

Bryan D. Carpenter 

Mr. Carpenter, 56, has had ITDM 

since 2007. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Carpenter understands diabetes 

management and monitoring, has stable 

control of his diabetes using insulin, 

and is able to drive a CMV safely. Mr. 

Carpenter meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

His optometrist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from North Carolina. 

Michael G. Cary 

Mr. Cary, 57, has had ITDM since 

1995. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Cary understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Cary meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he has stable nonproliferative diabetic 

retinopathy. He holds a Class A CDL 

from Minnesota. 

John G. Castilaw 

Mr. Castilaw, 50, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Castilaw understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Castilaw meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Mississippi. 

Dominick Cicala 

Mr. Cicala, 54, has had ITDM since 

2011. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Cicala understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Cicala meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from New Jersey. 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 3727 

Scott E. Cleveland 

Mr. Cleveland, 43, has had ITDM 

since 2010. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Cleveland understands diabetes 

management and monitoring, has stable 

control of his diabetes using insulin, 

and is able to drive a CMV safely. Mr. 

Cleveland meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

His optometrist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds an 

operator’s license from Kentucky. 

Adam C. Cochran 

Mr. Cochran, 25, has had ITDM since 

1991. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Cochran understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Cochran meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Georgia. 

Michael R. Cummings 

Mr. Cummings, 56, has had ITDM 

since 2010. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Cummings understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Cummings meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds an 

operator’s license from Virginia. 

David L. Dalheim 

Mr. Dalheim, 47, has had ITDM since 

2004. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Dalheim understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Dalheim meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from New York. 

Brian Dick 

Mr. Dick, 52, has had ITDM since 

2011. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Dick understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Dick meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

an operator’s license from Maryland. 

Timothy B. Duelke 

Mr. Duelke, 32, has had ITDM since 

2009. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Duelke understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Duelke meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Idaho. 

Cory A. Duncan 

Mr. Duncan, 40, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Duncan understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Duncan meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds an operator’s license from 

Oregon. 

Terrence J. Dunne 

Mr. Dunne, 49, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Dunne understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Dunne meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from New 

Jersey. 

David L. Eklund 

Mr. Eklund, 49, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Eklund understands 

diabetes management and monitoring, 

has stable control of his diabetes using 


tkelley on DSK3SPTVN1PROD with NOTICES
3728 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

insulin, and is able to drive a CMV 

safely. Mr. Eklund meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from Illinois. 

Yoshitsugu Endo 

Mr. Endo, 48, has had ITDM since 

2011. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Endo understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Endo meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 

he has stable nonproliferative diabetic 

retinopathy. He holds a Class A CDL 

from New York. 

Barry K. Foster 

Mr. Foster, 50, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Foster understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Foster meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from Texas. 

Robert Fugate 

Mr. Fugate, 58, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Fugate understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Fugate meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from Ohio. 

John A. Georg 

Mr. Georg, 61, has had ITDM since 

1986. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Georg understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Georg meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Iowa. 

Francis J. Gernatt, Jr. 

Mr. Gernatt, 68, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Gernatt understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Gernatt meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from New York. 

Mark A. Haines 

Mr. Haines, 50, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Haines understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Haines meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from West 

Virginia. 

Ivan G. Hanford 

Mr. Hanford, 48, has had ITDM since 

2010. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Hanford understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Hanford meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Oregon. 

James L. Harman, III 

Mr. Harman, 27, has had ITDM since 

1989. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Harman understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Harman meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds an 

operator’s license from Virginia. 

James R. Hoyle 

Mr. Hoyle, 34, has had ITDM since 

1997. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 3729 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Hoyle understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Hoyle meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Texas. 

George E. Huften 

Mr. Huften, 55, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Huften understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Huften meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Connecticut. 

John M. Ippolito 

Mr. Ippolito, 45, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Ippolito understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Ippolito meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from New 

York. 

Allan L. Jameson 

Mr. Jameson, 74, has had ITDM since 

2009. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Jameson understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Jameson meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class B CDL from Nebraska. 

Erik D. Kemmer 

Mr. Kemmer, 35, has had ITDM since 

2009. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Kemmer understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Kemmer meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Minnesota. 

Mark L. Knobel, Sr. 

Mr. Knobel, 55, has had ITDM since 

1987. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Knobel understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Knobel meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class C 

CDL from Maryland. 

Joseph E. Knox, Sr. 

Mr. Knox, 55, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Knox understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Knox meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

a Class B CDL from Maryland. 

Erik M. Lane 

Mr. Lane, 33, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Lane understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Lane meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from New York. 

Jacob C. Liebl 

Mr. Liebl, 23, has had ITDM since 

1996. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Liebl understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Liebl meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

an operator’s license from North Dakota. 

Galen H. Martin 

Mr. Martin, 69, has had ITDM since 

2011. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 


tkelley on DSK3SPTVN1PROD with NOTICES
3730 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Martin understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Martin meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Pennsylvania. 

James D. Martin 

Mr. Martin, 55, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Martin understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Martin meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Indiana. 

John M. McCabe 

Mr. McCabe, 43, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. McCabe understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. McCabe meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Illinois. 

Kevin F. McGlade 

Mr. McGlade, 54, has had ITDM since 

2000. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. McGlade understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. McGlade meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds an operator’s license from 

Pennsylvania. 

Brett J. Mellor 

Mr. Mellor, 31, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Mellor understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Mellor meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from Idaho. 

Kenneth M. Merritt 

Mr. Merritt, 50, has had ITDM since 

2007. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Merritt understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Merritt meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from California. 

Douglas D. Milligan 

Mr. Milligan, 63, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Milligan understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Milligan meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Washington. 

Charles E. Morgan 

Mr. Morgan, 62, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Morgan understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Morgan meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Louisiana. 

Richard D. Neal 

Mr. Neal, 59, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Neal understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Neal meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His ophthalmologist 

examined him in 2014 and certified that 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 3731 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Tennessee. 

Gary Anthony Alfred H. Nelson 

Mr. Nelson, 51, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Nelson understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Nelson meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Florida. 

Robert E. Perdue 

Mr. Perdue, 63, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Perdue understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Perdue meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Washington. 

Christie M. Rose 

Ms. Rose, 57, has had ITDM since 

2013. Her endocrinologist examined her 

in 2014 and certified that she has had 

no severe hypoglycemic reactions 

resulting in loss of consciousness, 

requiring the assistance of another 

person, or resulting in impaired 

cognitive function that occurred without 

warning in the past 12 months and no 

recurrent (2 or more) severe 

hypoglycemic episodes in the last 5 

years. Her endocrinologist certifies that 

Ms. Rose understands diabetes 

management and monitoring, has stable 

control of her diabetes using insulin, 

and is able to drive a CMV safely. Ms. 

Rose meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

Her optometrist examined her in 2014 

and certified that she does not have 

diabetic retinopathy. She holds a Class 

B CDL from Texas. 

John E. Sautkulis 

Mr. Sautkulis, 64, has had ITDM since 

2013. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Sautkulis understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Sautkulis meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from New York. 

Kevin D. Schlichting 

Mr. Schlichting, 52, has had ITDM 

since 2013. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Schlichting understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Schlichting meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Pennsylvania. 

Ronnie L. Schronce 

Mr. Schronce, 47, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Schronce understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Schronce meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from North Carolina. 

Richard A. Sharpe 

Mr. Sharpe, 45, has had ITDM since 

1993. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Sharpe understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Sharpe meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from 

Minnesota. 

William F. Smith 

Mr. Smith, 58, has had ITDM since 

2006. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Smith understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Smith meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds an 

operator’s license from Delaware. 

Richard W. Stultz 

Mr. Stultz, 61, has had ITDM since 

2012. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 


tkelley on DSK3SPTVN1PROD with NOTICES
3732 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 

the last 5 years. His endocrinologist 

certifies that Mr. Stultz understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Stultz meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds a chauffeur’s license from 

Indiana. 

Robin W. Swasey 

Mr. Swasey, 52, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Swasey understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Swasey meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Utah. 

Michelle P. Thibeault 

Ms. Thibeault, 45, has had ITDM 

since 1992. Her endocrinologist 

examined her in 2014 and certified that 

she has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. Her endocrinologist 

certifies that Ms. Thibeault understands 

diabetes management and monitoring 

has stable control of her diabetes using 

insulin, and is able to drive a CMV 

safely. Ms. Thibeault meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). Her 

ophthalmologist examined her in 2014 

and certified that she does not have 

diabetic retinopathy. She holds a Class 

B CDL from Maine. 

Michael L. Thrasher 

Mr. Thrasher, 54, has had ITDM since 

2014. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Thrasher understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Thrasher meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds a Class A CDL from Alabama. 

Melinda K. Topel 

Ms. Topel, 43, has had ITDM since 

2010. Her endocrinologist examined her 

in 2014 and certified that she has had 

no severe hypoglycemic reactions 

resulting in loss of consciousness, 

requiring the assistance of another 

person, or resulting in impaired 

cognitive function that occurred without 

warning in the past 12 months and no 

recurrent (2 or more) severe 

hypoglycemic episodes in the last 5 

years. Her endocrinologist certifies that 

Ms. Topel understands diabetes 

management and monitoring has stable 

control of her diabetes using insulin, 

and is able to drive a CMV safely. Ms. 

Topel meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

Her ophthalmologist examined her in 

2014 and certified that she has stable 

nonproliferative diabetic retinopathy. 

She holds a Class B CDL from Missouri. 

Steven R. Vance 

Mr. Vance, 46, has had ITDM since 

1995. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Vance understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Vance meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds an operator’s license from 

Texas. 

William D. VanReese 

Mr. VanReese, 38, has had ITDM 

since 2009. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. VanReese understands diabetes 

management and monitoring, has stable 

control of his diabetes using insulin, 

and is able to drive a CMV safely. Mr. 

VanReese meets the requirements of the 

vision standard at 49 CFR 391.41(b)(10). 

His optometrist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds an 

operator’s license from Minnesota. 

Ellis J. Vest, Jr. 

Mr. Vest, 52, has had ITDM since 

2011. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Vest understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Vest meets the requirements 

of the vision standard at 49 CFR 

391.41(b)(10). His optometrist examined 

him in 2014 and certified that he does 

not have diabetic retinopathy. He holds 

a Class A CDL from West Virgnia. 

Herbert E. Wachtel 

Mr. Wachtel, 46, has had ITDM since 

2006. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Wachtel understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Wachtel meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class A 

CDL from Minnesota. 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices 3733 

1Section 4129(a) refers to the 2003 notice as a 

‘‘final rule.’’ However, the 2003 notice did not issue 

a ‘‘final rule’’ but did establish the procedures and 

standards for issuing exemptions for drivers with 

ITDM. 

Kendall G. Webster 

Mr. Webster, 56, has had ITDM since 

2000. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Webster understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Webster meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he has stable 

nonproliferative diabetic retinopathy. 

He holds an operator’s license from 

Oregon. 

Christopher J. Wilson 

Mr. Wilson, 40, has had ITDM since 

2009. His endocrinologist examined him 

in 2014 and certified that he has had no 

severe hypoglycemic reactions resulting 

in loss of consciousness, requiring the 

assistance of another person, or 

resulting in impaired cognitive function 

that occurred without warning in the 

past 12 months and no recurrent (2 or 

more) severe hypoglycemic episodes in 

the last 5 years. His endocrinologist 

certifies that Mr. Wilson understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Wilson meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His optometrist 

examined him in 2014 and certified that 

he does not have diabetic retinopathy. 

He holds an operator’s license from 

Pennsylvania. 

Mark P. Zimmerman 

Mr. Zimmerman, 58, has had ITDM 

since 1999. His endocrinologist 

examined him in 2014 and certified that 

he has had no severe hypoglycemic 

reactions resulting in loss of 

consciousness, requiring the assistance 

of another person, or resulting in 

impaired cognitive function that 

occurred without warning in the past 12 

months and no recurrent (2 or more) 

severe hypoglycemic episodes in the 

last 5 years. His endocrinologist certifies 

that Mr. Zimmerman understands 

diabetes management and monitoring, 

has stable control of his diabetes using 

insulin, and is able to drive a CMV 

safely. Mr. Zimmerman meets the 

requirements of the vision standard at 

49 CFR 391.41(b)(10). His 

ophthalmologist examined him in 2014 

and certified that he does not have 

diabetic retinopathy. He holds a Class B 

CDL from Nevada. 

III. Request for Comments 

In accordance with 49 U.S.C. 31136(e) 

and 31315, FMCSA requests public 

comment from all interested persons on 

the exemption petitions described in 

this notice. We will consider all 

comments received before the close of 

business on the closing date indicated 

in the date section of the notice. 

FMCSA notes that section 4129 of the 

Safe, Accountable, Flexible and 

Efficient Transportation Equity Act: A 

Legacy for Users requires the Secretary 

to revise its diabetes exemption program 

established on September 3, 2003 (68 FR 

52441).1 The revision must provide for 

individual assessment of drivers with 

diabetes mellitus, and be consistent 

with the criteria described in section 

4018 of the Transportation Equity Act 

for the 21st Century (49 U.S.C. 31305). 

Section 4129 requires: (1) Elimination 

of the requirement for 3 years of 

experience operating CMVs while being 

treated with insulin; and (2) 

establishment of a specified minimum 

period of insulin use to demonstrate 

stable control of diabetes before being 

allowed to operate a CMV. 

In response to section 4129, FMCSA 

made immediate revisions to the 

diabetes exemption program established 

by the September 3, 2003 notice. 

FMCSA discontinued use of the 3-year 

driving experience and fulfilled the 

requirements of section 4129 while 

continuing to ensure that operation of 

CMVs by drivers with ITDM will 

achieve the requisite level of safety 

required of all exemptions granted 

under 49 U.S.C. 31136(e). 

Section 4129(d) also directed FMCSA 

to ensure that drivers of CMVs with 

ITDM are not held to a higher standard 

than other drivers, with the exception of 

limited operating, monitoring and 

medical requirements that are deemed 

medically necessary. 

The FMCSA concluded that all of the 

operating, monitoring and medical 

requirements set out in the September 3, 

2003 notice, except as modified, were in 

compliance with section 4129(d). 

Therefore, all of the requirements set 

out in the September 3, 2003 notice, 

except as modified by the notice in the 

Federal Register on November 8, 2005 

(70 FR 67777), remain in effect. 

IV. Submitting Comments 

You may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. 

To submit your comment online, go to 

http://www.regulations.gov and in the 

search box insert the docket number 

FMCSA–2014–0312 and click the search 

button. When the new screen appears, 

click on the blue ‘‘Comment Now!’’ 

button on the right hand side of the 

page. On the new page, enter 

information required including the 

specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. If you submit your 

comments by mail or hand delivery, 

submit them in an unbound format, no 

larger than 81⁄2 by 11 inches, suitable for 

copying and electronic filing. If you 

submit comments by mail and would 

like to know that they reached the 

facility, please enclose a stamped, selfaddressed postcard or envelope. 

We will consider all comments and 

material received during the comment 

period and may change this proposed 

rule based on your comments. FMCSA 

may issue a final rule at any time after 

the close of the comment period. 

V. Viewing Comments and Documents 

To view comments, as well as any 

documents mentioned in this preamble, 

To submit your comment online, go to 

http://www.regulations.gov and in the 

search box insert the docket number 

FMCSA–2014–0312 and click ‘‘Search.’’ 

Next, click ‘‘Open Docket Folder’’ and 

you will find all documents and 

comments related to the proposed 

rulemaking. 

Issued on: January 12, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–01198 Filed 1–22–15; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

National Highway Traffic Safety 

Administration 

Petition for Exemption From the 

Federal Motor Vehicle Theft Prevention 

Standard; Honda 

AGENCY: National Highway Traffic 

Safety Administration (NHTSA), 

Department of Transportation (DOT). 


tkelley on DSK3SPTVN1PROD with NOTICES